跳至主要内容
临床试验/NCT03248466
NCT03248466Unknown早期 1 期

Transplantation of Autologous Platelet Rich Gel Combined With Autologous Bone Marrow Mesenchymal Stem Cells for Treatment of Diabetic Foot Ulcer

Third Military Medical University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年8月30日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
入组人数
60
试验地点
2
主要终点
Amputation rate

研究概览

简要总结

To investigate the treatment effect between Traditional treatment and transplantation of autologous PRG combined with autologous BMMSCs for treatment of diabetic foot ulcer.

详细描述

60 diabetic foot ulcer in our hospital will divide into 3 groups: group A (20 diabetic foot ulcer who give Traditional treatment), group B (20 diabetic foot ulcer who give Traditional treatment and transplantation of autologous platelet rich gel),group C (20 diabetic foot ulcer who give Traditional treatment and transplantation of autologous platelet rich gel combined with autologous bone marrow mesenchymal stem cells). The age, height, weight, blood glucose, glycosylated hemoglobin A1c(HbA1c), lipid, blood pressure, course of disease, Wound healing rate,transcutaneous oxygen pressure,Amputation rate,Hospital stay will record respectively. And High-sensitive C-reactive protein (HsCRP) and Tumor necrosis factor-α(TNF-α) will detect as Baseline. After each group's treatment, Change from baseline of all indexes will record, one way Analysis of Variance will be analyzed the significantion among 3 groups.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetic foot according to The Wagner is 2-3 graded;

排除标准

  • Type 1 diabetes mellitus,presence of autoimmune diabetes;
  • Gestational diabetes;
  • Patients with heart, liver, or renal function impairment;presence of severe infections or cerebrovascular disease.

研究组 & 干预措施

Traditional treatment

Placebo Comparator

Traditional treatment such as insulin,antidiabetes,dressing

干预措施: PRG combined with BMMSCs transplantation (Biological)

PRG combined with BMMSCs transplantation

Experimental

Traditional treatment such as insulin,antidiabetes,dressing and Autologous PRG combined with BMMSCs

干预措施: PRG combined with BMMSCs transplantation (Biological)

PRG treatment

No Intervention

Traditional treatment such as insulin,antidiabetes,dressing and Autologous PRG

结局指标

主要结局

Amputation rate

时间窗: up to 6 months

Amputation rate up to 6 months

hospital stay

时间窗: up to 6 months

hospital stay

次要结局

  • Wound healing time(up to 6 months)
  • Transcutaneous oxygen partial pressure(Transcutaneous oxygen partial pressure up to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wu Qinan

Doctor

Third Military Medical University

研究点 (2)

Loading locations...

相似试验